COVID-19 and teletherapy may be changing how much you know about your therapist
BeiGene Begins Commercializing Xgeva In China For Giant Cell Tumors
Medical cannabis ETFs on cusp of mainstream breakthrough
Coronavirus: the antibody drugs few people have been discussing – until now
US advisors add steroids to COVID-19 drug recommendations
Gilead Sets Pricing For Remdesivir Vaccine At $2,340 Per Patient
V-Shaped Narrative Dies As Commercial Real Estate Bust Accelerates
Inovio adds two to the leadership team; Adrian Woolfson is out at Sangamo
3 Biotech Stocks Under $5 With 100%-Plus Upside Potential
Entos Pharmaceuticals announces selection of lead DNA vaccine candidates for COVID-19
3 Under-the-Radar Penny Stocks Gearing up for Gains
Top Analysts See 100%-Plus Upside Potential in These 3 Penny Stocks
Top Analysts Bet on These 3 Penny Stocks; See 100%-Plus Upside Potential
Gene therapy and CRISPR strategies for curing blindness (Yes, you read that right)
COVID-19: Bacteriophage could decrease mortality
Germany first in EU to get Novartis’ SMA gene therapy, costing almost 2m euros
Pluristem Is a High Risk, High Reward Play, Says Jefferies Analyst
A furry social robot can reduce pain and increase happiness — Ben-Gurion University researchers
Nurturing A Culture Of “Smart Speed” To Bring Gene Therapy To The World
3 "Perfect 10" Stocks Under $10 With Big Upside Potential
Females use anti-inflammatory T cells to keep their blood pressure down
Gilead Aims To Produce More Than 2 Million Remdesivir Courses By Year-End
New article clarifies details of COVID-19 respiratory transmission
Poseida Therapeutics aims for $115m stock market launch to fund CAR-T R&D
The right way to breathe during the coronavirus pandemic
Boehringer Ingelheim nabs new US president and CEO; AstraZeneca vet hops aboard Novavax as CMO
2 “Strong Buy” Small-Cap Stocks That Could See Outsized Gains
Emergent Makes $75 Million Investment To Boost Viral Vaccine Capabilities
Gilead will test remdesivir in children with COVID-19
3 Pharmaceutical Stocks With Major Catalysts Approaching